Multivariate RNA Modeling Techniques Predicts Immune Checkpoint Responders
SAN FRANCISCO, Feb. 28, 2020 (CLINICAL OMICS) – A retrospective study among head and neck cancer patients found that a multivariate RNA biomarker test performed equally as standard PD-L1 [...]
The Innovators 2019
SAN FRANCISCO, Dec. 16, 2019 (THE PATHOLOGIST) – Showcasing the latest techniques and technologies from industry innovators around the globe.
Cognitive Take on RNA Elevates Biomarker Development, Advances Precision Medicine
SAN FRANCISCO, Dec. 2, 2019 (GENENGNEWS) – Machine learning, says Cofactor Genomics, moves RNA-seq to RNA models, enables multidimensional biomarkers.
Cofactor Genomics to Provide Solid Tumor Immune Profiling for Genocea Biosciences
SAN FRANCISCO, Dec. 4, 2018 (BUSINESS WIRE) – Cofactor Genomics, a clinical RNA sequencing and translational assay developer, today announced a pilot study to evaluate use of Cofactor’s [...]
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrism
SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) — Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today that its laboratory has successfully [...]